Pfizer raises full-year outlook on covid-19 vaccine sales
- The pharmaceutical giant’s quarterly revenue nearly doubled year over year
Pfizer Inc. raised its full-year forecast for sales of its Covid-19 vaccine to about $33.5 billion, a nearly 30% increase, helping lift the pharmaceutical giant’s overall estimates for its sales and profits in 2021.